StocksC › CRVL

CorVel Corporation (CRVL) — Earnings Call X-Ray

Our AI read all 30 of CRVL's earnings calls (2016–2023) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q2 2024 · sign up to see
Previous Call Grade
C
Q2 2022
Expected Move
🔒
next 45 days · members
Calls Analyzed
30
2016–2023
Avg Candor
5.8/9
evasion 1.2/9
Critic AmmunitionEarly Product, Fast GrowthUnderused Fixed CostsMargins ContractingCapex IncreasingReads RehearsedQuestion Left HangingResults Worse Than Direction

Call-by-call analysis

🔒 Q2 2024 earnings call 2023-10-31 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q2 2024 call grade is ready
The full 37-point AI read of CRVL's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q2 2022 earnings call 2022-11-01

Management gave no formal guidance against steady demand and contracting margins. The delivery was rich in specifics.

Demand: stableMargins: contractingHeadcount: growingCapex: increasing
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q1 2022 earnings call 2022-08-06

Management gave no formal guidance against accelerating demand and contracting margins.

Demand: acceleratingMargins: contractingHeadcount: growingCapex: increasing
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedDirection beats results
Candor 5/9
Specificity 6/9
Evasion 0/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q4 2022 earnings call 2022-05-26

Management gave no formal guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Demand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: growing
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growth⚑ Reads rehearsed
Candor 4/9
Specificity 7/9
Evasion 0/9
Confidence 8/9
Uncertainty 2/9
Promotion 7/9
Stress 1/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q3 2022 earnings call 2022-02-01

Management gave no formal guidance against accelerating demand and contracting margins. The delivery was rich in specifics.

Demand: acceleratingMargins: contractingBacklog: growingPricing: under pressureHeadcount: growingCapex: increasing
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 0/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q2 2021 earnings call 2021-11-02

Management gave no formal guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning.

Demand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: increasing
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 0/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q1 2022 earnings call 2021-08-07

Management gave no formal guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning.

Demand: acceleratingMargins: expandingPricing: stableCapex: increasing
⚑ Critic ammunition✓ Skeptic reassured✓ Resolves doubts⚑ Reads rehearsed
Candor 5/9
Specificity 7/9
Evasion 0/9
Confidence 8/9
Uncertainty 2/9
Promotion 6/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B+ Q1 2021 earnings call 2021-05-27

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning.

Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: growing
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 0/9
Confidence 8/9
Uncertainty 4/9
Promotion 5/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2020 2021-02-02 C nonemixedexpanding 5/9 0/9
Q3 2020 2020-11-03 C noneslowingexpanding 6/9 2/9
Q3 2020 2020-11-03 D nonemixedexpanding 6/9 0/9
Q2 2020 2020-08-08 C nonemixedcontracting 6/9 2/9
Q4 2020 2020-05-27 D nonemixedcontracting 6/9 2/9
Q4 2019 2020-02-04 D maintainedmixedcontracting 6/9 2/9
Q3 2019 2019-11-09 D nonemixedexpanding 5/9 2/9
Q1 2019 2019-07-30 F nonemixedexpanding 6/9 3/9
Q4 2018 2019-05-30 C+ nonemixedexpanding 5/9 0/9
Q3 2018 2019-02-05 D nonemixedexpanding 6/9 2/9
Q2 2019 2018-10-30 D nonestableexpanding 5/9 0/9
Q1 2019 2018-07-31 C+ noneacceleratingexpanding 5/9 2/9
Q4 2018 2018-05-31 C nonemixedcontracting 7/9 2/9
Q3 2018 2018-01-30 D nonestablecontracting 6/9 2/9
Q2 2018 2017-10-31 D nonemixedstable 7/9 2/9
Q1 2018 2017-08-01 C nonestableexpanding 5/9 0/9
Q4 2017 2017-06-01 D nonemixedcontracting 7/9 2/9
Q3 2017 2017-01-31 D maintainedmixedcontracting 6/9 2/9
Q2 2017 2016-11-01 F nonemixedcontracting 7/9 3/9
Q1 2017 2016-08-02 D nonemixedcontracting 7/9 0/9
Q4 2016 2016-06-02 D nonestableexpanding 6/9 2/9
Q4 2015 2016-02-02 D nonemixedcontracting 6/9 2/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

CRUS   All “C” companies    CRVS

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.